Literature DB >> 21906802

Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function.

Brian Liau1, Nicolas Christoforou, Kam W Leong, Nenad Bursac.   

Abstract

Recent advances in pluripotent stem cell research have provided investigators with potent sources of cardiogenic cells. However, tissue engineering methodologies to assemble cardiac progenitors into aligned, 3-dimensional (3D) myocardial tissues capable of physiologically relevant electrical conduction and force generation are lacking. In this study, we introduced 3D cell alignment cues in a fibrin-based hydrogel matrix to engineer highly functional cardiac tissues from genetically purified mouse embryonic stem cell-derived cardiomyocytes (CMs) and cardiovascular progenitors (CVPs). Procedures for CM and CVP derivation, purification, and functional differentiation in monolayer cultures were first optimized to yield robust intercellular coupling and maximize velocity of action potential propagation. A versatile soft-lithography technique was then applied to reproducibly fabricate engineered cardiac tissues with controllable size and 3D architecture. While purified CMs assembled into a functional 3D syncytium only when supplemented with supporting non-myocytes, purified CVPs differentiated into cardiomyocytes, smooth muscle, and endothelial cells, and autonomously supported the formation of functional cardiac tissues. After a total culture time similar to period of mouse embryonic development (21 days), the engineered cardiac tissues exhibited unprecedented levels of 3D organization and functional differentiation characteristic of native neonatal myocardium, including: 1) dense, uniformly aligned, highly differentiated and electromechanically coupled cardiomyocytes, 2) rapid action potential conduction with velocities between 22 and 25 cm/s, and 3) significant contractile forces of up to 2 mN. These results represent an important advancement in stem cell-based cardiac tissue engineering and provide the foundation for exploiting the exciting progress in pluripotent stem cell research in the future tissue engineering therapies for heart disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906802      PMCID: PMC3190071          DOI: 10.1016/j.biomaterials.2011.08.050

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  64 in total

1.  Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity.

Authors:  Rajesh B Sekar; Eddy Kizana; Rachel R Smith; Andreas S Barth; Yibing Zhang; Eduardo Marbán; Leslie Tung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-03       Impact factor: 4.733

2.  Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Authors:  Oren Caspi; Ayelet Lesman; Yaara Basevitch; Amira Gepstein; Gil Arbel; Irit Huber Manhal Habib; Lior Gepstein; Shulamit Levenberg
Journal:  Circ Res       Date:  2007-01-11       Impact factor: 17.367

3.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart.

Authors:  Harald C Ott; Thomas S Matthiesen; Saik-Kia Goh; Lauren D Black; Stefan M Kren; Theoden I Netoff; Doris A Taylor
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

4.  Novel anisotropic engineered cardiac tissues: studies of electrical propagation.

Authors:  Nenad Bursac; Yihua Loo; Kam Leong; Leslie Tung
Journal:  Biochem Biophys Res Commun       Date:  2007-08-02       Impact factor: 3.575

Review 5.  Fibrin gels and their clinical and bioengineering applications.

Authors:  Paul A Janmey; Jessamine P Winer; John W Weisel
Journal:  J R Soc Interface       Date:  2009-01-06       Impact factor: 4.118

Review 6.  Stem-cell-based therapy and lessons from the heart.

Authors:  Robert Passier; Linda W van Laake; Christine L Mummery
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

7.  Contractile three-dimensional bioengineered heart muscle for myocardial regeneration.

Authors:  Yen-Chih Huang; Luda Khait; Ravi K Birla
Journal:  J Biomed Mater Res A       Date:  2007-03-01       Impact factor: 4.396

8.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

9.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.

Authors:  Lei Yang; Mark H Soonpaa; Eric D Adler; Torsten K Roepke; Steven J Kattman; Marion Kennedy; Els Henckaerts; Kristina Bonham; Geoffrey W Abbott; R Michael Linden; Loren J Field; Gordon M Keller
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

10.  Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes.

Authors:  Nicolas Christoforou; Ronald A Miller; Christine M Hill; Chunfa C Jie; Andrew S McCallion; John D Gearhart
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more
  89 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 2.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

3.  Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Maureen Wanjare; Luqia Hou; Karina H Nakayama; Joseph J Kim; Nicholas P Mezak; Oscar J Abilez; Evangeline Tzatzalos; Joseph C Wu; Ngan F Huang
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

4.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

5.  Temporal Impact of Substrate Anisotropy on Differentiating Cardiomyocyte Alignment and Functionality.

Authors:  Alicia C B Allen; Elissa Barone; Nima Momtahan; Cody O Crosby; Chengyi Tu; Wei Deng; Krista Polansky; Janet Zoldan
Journal:  Tissue Eng Part A       Date:  2019-08-20       Impact factor: 3.845

6.  Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.

Authors:  Ze-Wei Tao; Mohamed Mohamed; Matthew Hogan; Laura Gutierrez; Ravi K Birla
Journal:  J Tissue Eng Regen Med       Date:  2014-04-28       Impact factor: 3.963

7.  Cardiac fibroblasts support endothelial cell proliferation and sprout formation but not the development of multicellular sprouts in a fibrin gel co-culture model.

Authors:  Rachel L Twardowski; Lauren D Black
Journal:  Ann Biomed Eng       Date:  2014-01-17       Impact factor: 3.934

Review 8.  Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling.

Authors:  Nethika R Ariyasinghe; Davi M Lyra-Leite; Megan L McCain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

Review 9.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

Review 10.  Fibrous scaffolds for building hearts and heart parts.

Authors:  A K Capulli; L A MacQueen; Sean P Sheehy; K K Parker
Journal:  Adv Drug Deliv Rev       Date:  2015-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.